Novozymes A/S (OTCMKTS:NVZMF – Get Rating) is one of 350 public companies in the “Biotechnology” industry, but how does it weigh in compared to its peers? We will compare Novozymes A/S to related companies based on the strength of its valuation, institutional ownership, analyst recommendations, risk, earnings, dividends and profitability. Analyst Recommendations This is a […]